Activity outcomes after hip arthroplasty: an information tool based on patients' experience captured in a hospital registry.
Cole S. et al, (2025), BMC Musculoskelet Disord, 26
Trends and variation in the incidence of hip fracture in England before, during, and after the COVID-19 pandemic (2014-2024): a population-based observational study
Webster J. et al, (2025), The Lancet Regional Health. Europe
Temporal trends in hospital-recorded pulmonary embolism in England before, during and after the COVID-19 pandemic (2008–2024): a population-based observational study
Zhong X. et al, (2025), The Lancet Regional Health. Europe
Correction: Children's Health in London and Luton (CHILL) cohort: a 12-month natural experimental study of the effects of the Ultra Low Emission Zone on children's travel to school.
Xiao C. et al, (2025), Int J Behav Nutr Phys Act, 22
Lottery or Triage? Multi-country survey-based experiment evidence from the COVID-19 pandemic on public preferences for allocation of scarce medical resources
Duch R., (2025), Medical decision making
Psychometric properties of the ICECAP-SCM capability-wellbeing measure in specialist palliative care units in Austria
Saly E. et al, (2025), Quality of Life Research
Gabapentin for pain management following major surgery: a placebo controlled, double blind, randomized clinical trial (The GAP Study).
Baos S. et al, (2025), Anesthesiology
Stereotactic radiotherapy for nAMD: areas for improvement - Authors' reply.
Jackson TL. et al, (2025), Lancet, 406, 26 - 27
Non-mental health inpatient and emergency care hospital costs associated with four mental disorders in Europe: a modelling study
Wienand D. et al, (2025), Lancet Psychiatry, 12, 513 - 523
Comparisons of Preferences Towards EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives.
Au ICH. et al, (2025), Value Health
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK.
Browning M. et al, (2025), Lancet Psychiatry
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
Zhou J. et al, (2025), EClinicalMedicine
Does the Risk Premium Differ Between Women Engaging in Commercial and Transactional Sex? Evidence From Urban Cameroon.
Njuguna RG. et al, (2025), Health Econ
Trends in mortality in people with heart failure and atrial fibrillation: population-based cohort study
JONES N. et al, (2025), The Lancet Healthy Longevity
Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England
Buckell J. et al, (2025), British Journal of Cancer